PharmaBoardroom

New China President for MSD Amid Changes at HQ & Access…

MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its strategically important China…

China’s New Era of Reform Transforming Regulatory Professionals

Writing in the June edition of DIA's Global Forum magazine, Harbour BioMed's Fang Zhou, in conversation with Sanofi China's Irene Deng, looks at how…

HKEX’s Aim to Become World’s #1 Biotech Listing Hub &…

With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs to IPO, we look back at a stellar…

Dun Yang – President & CEO, Anticancer Bioscience

Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer…

Roche Hoping to Spearhead ‘Created in China’ Push with New…

In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai, a USD 31.1 million investment aiming to foster and capitalise on…

China Pharma News: BioNTech-Fosun JV; Patent Law Revamp; Hong…

The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up on COVID-19 vaccines; and big…

APAC: Generic Penetration by Country

Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3 percent of all medicines dispensed in India were generics compared to…

APAC: How Precision Medicine is Transforming the Oncology…

Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year and with deaths caused by cancer expected to increase by 36 percent by…

China: EpimAb Looks to 2022 IPO & Global Leadership in…

Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking towards a 2022 IPO with the aim of…

Sizhen Wang – CEO & Co-Founder, Genetron Health

Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of cancer care, from early screening,…

China Pharma News: Antitrust Threat to Pharma; June BioNTech…

The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in June; the potential of Western China as…

Boehringer Ingelheim’s Stroke Rehab Centre Success &…

In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas Rehabilitation and the Shanghai International Medical Center (SIMC) jointly…

Tagged with China